Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿©¼º º¹¾Ð¼º¿ä½Ç±Ý ȯÀÚ¿¡¼­ IRIS ¼ú½ÄÀÇ 5³â ÃßÀû °á°ú: TVT ¼ú½Ä°úÀÇ ºñ±³ Five-Year Outcomes of the IRIS Procedure for the Treatment of Female Stress Urinary Incontinence: Comparison with the TVT Procedure

´ëÇѺñ´¢±â°úÇÐȸÁö 2009³â 50±Ç 8È£ p.767 ~ 773
¼ÛÇÊÇö, Çöâȣ, ÀÓÈ­¼ö, Á¤Èñâ,
¼Ò¼Ó »ó¼¼Á¤º¸
¼ÛÇÊÇö ( Song Phil-Hyun ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Çöâȣ ( Hyun Chang-Ho ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÀÓÈ­¼ö ( Lim Hwa-Su ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¤Èñâ ( Jung Hee-Chang ) 
¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract


Purpose: We evaluated the long-term efficacy and safety of the innovative replacement of incontinence surgery (IRIS) procedure and compared these with the tension-free vaginal tape (TVT) procedure for the treatment of female stress urinary incontinence.

Materials and Methods : We included 111 consecutively treated women who underwent IRIS (n=51) or TVT (n=60) between January 2002 and December 2003 and followed them up for at least 5 years postoperatively. We analyzed the 5-year success rate and postoperative complications of the IRIS procedure and compared these with the results of the TVT procedure.

Results: The 5-year success rate was 92.2% for the IRIS procedure and 93.3% for the TVT procedure, and the satisfaction rates were 90.2% and 85.0%, respectively. Intraoperative complications for the IRIS group included 4 cases of bladder perforation, and there were 5 cases of bladder perforation in the TVT group. The postoperative complications for the IRIS group included 3 patients with de novo urgency, 2 patients with mesh exposure, and 1 patient with temporary urinary retention. Four patients in the TVT group developed de novo urgency, 2 patients had mesh exposure, and 2 patients showed temporary urinary retention.

Conclusions: Our results suggest that IRIS may be an effective and safe procedure compared with the TVT procedure for more than 5 years. (Korean J Urol 2009;50:767-773)

Å°¿öµå

Stress urinary incontinence;Urologic surgical procedures

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS